ClinConnect ClinConnect Logo
Search / Trial NCT06735859

Eating Window and Sleep Disorders on Glycemic Control, Cardiovascular Risk, and Weight Loss

Launched by FEDERAL UNIVERSITY OF SÃO PAULO · Dec 11, 2024

Trial Information

Current as of November 10, 2025

Not yet recruiting

Keywords

Type 2 Diabetes Hypertension Obesity Cardiovascular Diseases Nutritional Intervention Sleep Eating Window

ClinConnect Summary

This clinical trial is looking to understand how changing eating habits and sleep patterns can help improve health outcomes for people with conditions like Type 2 Diabetes, obesity, and high blood pressure. The main goals are to help participants establish regular eating schedules, improve their health measurements (like weight and blood pressure), and learn more about healthy eating habits. Participants will go through various assessments related to their health and diet over the course of 18 months.

To join the study, you need to be an adult between the ages of 18 and 80, and have a diagnosis of obesity, diabetes, or high blood pressure. The trial is open to both men and women, and participants must be able to attend meetings every three months. However, if you are already exercising regularly, using certain diabetes medications, or have kidney problems, you may not be eligible to participate. If you decide to take part, you can expect to receive support and education on nutrition while contributing to important research that could help others with similar health issues.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age: Adults \>18 years \< 80 years; Diagnosis of obesity, diabetes, and hypertension; Gender: Male and female; Availability to attend quarterly meetings over a period of 18 months; Sedentary.
  • Exclusion Criteria:
  • Difficulties in responding to the requested instruments; Impediments to regular attendance in data collection; No diagnosis of Obesity, Diabetes, and Hypertension; Use of insulin therapy, Sodium-Glucose Cotransporter-2 (SGLT-2) inhibitors, and Glucagon-Like Peptide-1 (GLP-1) analogs; Chronic Kidney Disease patients; Normal weight or undernourished individuals; Physical exercise practitioners (\>150 minutes of exercise/week).

About Federal University Of São Paulo

The Federal University of São Paulo (Universidade Federal de São Paulo - UNIFESP) is a prestigious institution dedicated to advancing education, research, and healthcare in Brazil. Renowned for its commitment to innovation and excellence, UNIFESP plays a pivotal role in clinical research, focusing on a multidisciplinary approach to improve health outcomes. The university fosters collaboration among researchers, healthcare professionals, and community stakeholders, ensuring that clinical trials conducted under its auspices adhere to rigorous ethical standards and contribute valuable insights to the medical field. With a rich history of academic achievement and a strong emphasis on translational research, UNIFESP is a key player in the development of new therapies and medical interventions.

Locations

Santos, São Paulo, Brazil

Santos, Brazil

Patients applied

0 patients applied

Trial Officials

Luciana P Pisani, PhD

Principal Investigator

Federal University of São Paulo

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported